ProvaLabs Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $1.39M

  • Investors
  • 4

ProvaLabs General Information

Description

Developer of microfluidic biochips with integrated electrical sensors intended for preclinical drug development. The company's biochip combines 3D cell culture technology with microfluidics to create complex biomimetic chips, replicating the in-body environment for 3D tissue structure imitation and phenotypic research, enabling researchers to select suitable drug candidates with higher accuracy and efficiency, ultimately accelerating the development of life-saving therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 337, Research Park Main Building
  • 1 Gwanak-ro, Gwanak-gu
  • Seoul
  • South Korea
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Vertical(s)
Life Sciences, Internet of Things
Corporate Office
  • Room 337, Research Park Main Building
  • 1 Gwanak-ro, Gwanak-gu
  • Seoul
  • South Korea

ProvaLabs Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProvaLabs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 29-Apr-2026 $1.39M Completed Startup
2. Seed Round 05-Feb-2024 Completed Startup
1. Accelerator/Incubator 29-Nov-2023 Completed Startup
To view ProvaLabs’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

ProvaLabs Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • 13

    Pending

  • Expiring in next 12 mo

ProvaLabs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026106255-A1 Well plate and base plate apparatus for implementing high-speed drug screening using a three-dimensional biological model Pending 14-Nov-2024
WO-2026106254-A1 Well plate device implementing high-speed drug screening based on three-dimensional biological model Pending 14-Nov-2024
WO-2026084441-A1 Device and method for nanoelectrohydrodynamics-based target detection Pending 15-Oct-2024
WO-2026038853-A1 Apparatus and method for multimodal analysis of three-dimensional biological model such as organoid Pending 14-Aug-2024
WO-2025183400-A1 Device for performing non-invasive multi-analysis of biological tissues such as skin Pending 26-Feb-2024
To view ProvaLabs’s complete patent history, request access »

ProvaLabs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProvaLabs Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capstone Partners Investment Bank Minority
Life Asset Management Hedge Fund Minority
Seoul National University Technology Holdings Accelerator/Incubator Minority
D-Camp Accelerator/Incubator Minority
To view ProvaLabs’s complete investors history, request access »

Ready to get started?

Request a free trial

ProvaLabs FAQs

  • When was ProvaLabs founded?

    ProvaLabs was founded in 2021.

  • Where is ProvaLabs headquartered?

    ProvaLabs is headquartered in Seoul, South Korea.

  • What is the size of ProvaLabs?

    ProvaLabs has 3 total employees.

  • What industry is ProvaLabs in?

    ProvaLabs’s primary industry is Biotechnology.

  • Is ProvaLabs a private or public company?

    ProvaLabs is a Private company.

  • What is ProvaLabs’s current revenue?

    The current revenue for ProvaLabs is .

  • How much funding has ProvaLabs raised over time?

    ProvaLabs has raised $1.01M.

  • Who are ProvaLabs’s investors?

    Capstone Partners, Life Asset Management, Seoul National University Technology Holdings, and D-Camp have invested in ProvaLabs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process